Panagora Asset Management’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-438,606
| Closed | -$2.03M | – | 2737 |
|
|
2019
Q1 | $2.03M | Buy |
438,606
+145,381
| +50% | +$688K | 0.01% | 830 |
|
|
2018
Q4 | $1.03M | Buy |
293,225
+7,579
| +3% | +$52.7K | ﹤0.01% | 1070 |
|
|
2018
Q3 | $2.88M | Buy |
285,646
+100,637
| +54% | +$803K | 0.01% | 714 |
|
|
2018
Q2 | $1.34M | Sell |
185,009
-143,660
| -44% | -$1M | 0.01% | 1038 |
|
|
2018
Q1 | $1.99M | Buy |
328,669
+115,878
| +54% | +$957K | 0.01% | 878 |
|
|
2017
Q4 | $2.05M | Buy |
212,791
+104,375
| +96% | +$683K | 0.01% | 873 |
|
|
2017
Q3 | $963K | Buy |
108,416
+107,057
| +7,878% | +$1.1M | ﹤0.01% | 1134 |
|
|
2017
Q2 | $17K | Hold |
1,359
| – | – | ﹤0.01% | 2318 |
|
|
2017
Q1 | $14K | Hold |
1,359
| – | – | ﹤0.01% | 2236 |
|
|
2016
Q4 | $12K | Sell |
1,359
-5,101
| -79% | -$57.6K | ﹤0.01% | 2278 |
|
|
2016
Q3 | $76K | Buy |
6,460
+5,101
| +375% | +$77.5K | ﹤0.01% | 2032 |
|
|
2016
Q2 | $18K | Sell |
1,359
-4,134
| -75% | -$60.3K | ﹤0.01% | 2178 |
|
|
2016
Q1 | $88K | Buy |
5,493
+4,134
| +304% | +$78.5K | ﹤0.01% | 1890 |
|
|
2015
Q4 | $39K | Hold |
1,359
| – | – | ﹤0.01% | 2041 |
|
|
2015
Q3 | $39K | Sell |
1,359
-6,697
| -83% | -$246K | ﹤0.01% | 2054 |
|
|
2015
Q2 | $289K | Sell |
8,056
-3,552
| -31% | -$111K | ﹤0.01% | 1528 |
|
|
2015
Q1 | $337K | Buy |
11,608
+5,846
| +101% | +$155K | ﹤0.01% | 1474 |
|
|
2014
Q4 | $121K | Sell |
5,762
-1,656
| -22% | -$32.7K | ﹤0.01% | 1806 |
|
|
2014
Q3 | $144K | Sell |
7,418
-2,526
| -25% | -$39.7K | ﹤0.01% | 1734 |
|
|
2014
Q2 | $155K | Sell |
9,944
-16,300
| -62% | -$263K | ﹤0.01% | 1799 |
|
|
2014
Q1 | $543K | Buy |
26,244
+17,955
| +217% | +$356K | ﹤0.01% | 1390 |
|
|
2013
Q4 | $107K | Hold |
8,289
| – | – | ﹤0.01% | 1836 |
|
|
2013
Q3 | $95K | Buy |
+8,289
| New | +$68.1K | ﹤0.01% | 1876 |
|
Other funds holding INSY
WS
Panagora Asset Management's INSY Position: Q2 2019 in Review
Panagora Asset Management sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 438,606 shares — an estimated $2.03M sold.
Panagora Asset Management first reported a position in INSY in Q3 2013 and held it in 23 quarters. The position peaked at $2.88M in Q3 2018. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- Panagora Asset Management reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- Panagora Asset Management sold 438,606 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $2.03M.
- Panagora Asset Management first reported a position in Insys Therapeutics, Inc. in Q3 2013 and held it in 23 quarters.
- Panagora Asset Management's Insys Therapeutics, Inc. position peaked at $2.88M in Q3 2018.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on Panagora Asset Management's 13F filing for Q2 2019, filed 9 Aug 2019.